Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carmot Therapeutics
Biotech
Roche hopes obesity drug will show 25% weight loss one day
Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials.
James Waldron
Sep 11, 2024 11:45am
Roche’s $2.7B weight-loss wager delivers early oral GLP-1 win
Jul 17, 2024 6:00am
Top 10 smartest deals in biopharma
Jun 24, 2024 6:00am
Roche's $2.7B Carmot bet pays off with ph. 1 weight loss success
May 16, 2024 5:29am
UPDATE: Roche muscles in on obesity market with $2.7B Carmot buy
Dec 4, 2023 5:26am
Carmot files for IPO, heating up icy market waters
Nov 20, 2023 11:15am
